SOPHiA GENETICS SA Research and Development Expense
SOPHiA GENETICS SA (SOPH) reported Research and Development Expense of $34.22 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-03
- SOPHiA GENETICS SA research and development expense for the quarter ending 2025-06-30 was $8.49M, a 6.72% increase year-over-year.
- SOPHiA GENETICS SA research and development expense for the quarter ending 2024-06-30 was $7.96M, a 10.49% decline year-over-year.
- SOPHiA GENETICS SA research and development expense for the quarter ending 2023-06-30 was $8.89M, a 1.10% decline year-over-year.
- SOPHiA GENETICS SA research and development expense for the quarter ending 2022-06-30 was $8.99M.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $34.22M 20-F · filed 2026-03-03 | ||
| 2025-06-30 | $8.49M 6-K · filed 2025-08-05 | $17.61M 6-K · filed 2025-08-05 | |
| 2024-12-31 | $34.37M 20-F · filed 2026-03-03 | ||
| 2024-06-30 | $7.96M 6-K · filed 2025-08-05 | $17.35M 6-K · filed 2025-08-05 | |
| 2023-12-31 | $36.97M 20-F · filed 2026-03-03 | ||
| 2023-06-30 | $8.89M 6-K · filed 2024-08-06 | $18.23M 6-K · filed 2024-08-06 | |
| 2022-12-31 | $35.37M 20-F · filed 2025-03-04 | ||
| 2022-06-30 | $8.99M 6-K · filed 2023-08-08 | $18.46M 6-K · filed 2023-08-08 | |
| 2021-12-31 | $26.58M 20-F · filed 2024-03-05 | ||
| 2020-12-31 | $18.59M 20-F · filed 2023-03-07 | ||
| 2019-12-31 | $15.02M 20-F · filed 2022-03-15 |